News + Filings Holdings
|
Atlas Venture Associates IX, LLC
> NTLA
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Intellia Therapeutics, Inc. | NTLA | 10,000 | 0 | 407,800,000 | 35,100,000 | $40,780.00 |
| 03/31/2023 | Intellia Therapeutics, Inc. | NTLA | 10,000 | 0 | 372,700,000 | 23,800,000 | $37,270.00 |
| 12/31/2022 | Intellia Therapeutics, Inc. | NTLA | 10,000 | 0 | 348,900,000 | 348,340,000 | $34,890.00 |
| 09/30/2022 | Intellia Therapeutics, Inc. | NTLA | 10,000 | 0 | 560,000 | 42,000 | $56.00 |
| 06/30/2022 | Intellia Therapeutics, Inc. | NTLA | 10,000 | 0 | 518,000 | -209,000 | $51.80 |
| 03/31/2022 | Intellia Therapeutics, Inc. | NTLA | 10,000 | 0 | 727,000 | -455,000 | $72.70 |
| 12/31/2021 | Intellia Therapeutics, Inc. | NTLA | 10,000 | 0 | 1,182,000 | -160,000 | $118.20 |
| 09/30/2021 | Intellia Therapeutics, Inc. | NTLA | 10,000 | 0 | 1,342,000 | -276,000 | $134.20 |
| 06/30/2021 | Intellia Therapeutics, Inc. | NTLA | 10,000 | -1,103,376 | 1,618,000 | -87,741,000 | $161.80 |
| 03/31/2021 | Intellia Therapeutics, Inc. | NTLA | 1,113,376 | -501,945 | 89,359,000 | 1,486,000 | $80.26 |
| 12/31/2020 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 87,873,000 | 55,760,000 | $54.40 |
| 09/30/2020 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 32,113,000 | -1,841,000 | $19.88 |
| 06/30/2020 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 33,954,000 | 14,198,000 | $21.02 |
| 03/31/2020 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 19,756,000 | -3,941,000 | $12.23 |
| 12/31/2019 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 23,697,000 | 2,133,000 | $14.67 |
| 09/30/2019 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 21,564,000 | -4,879,000 | $13.35 |
| 06/30/2019 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 26,443,000 | -1,147,000 | $16.37 |
| 03/31/2019 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 27,590,000 | 5,541,000 | $17.08 |
| 12/31/2018 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | 0 | 22,049,000 | -24,181,000 | $13.65 |
| 09/30/2018 | Intellia Therapeutics, Inc. | NTLA | 1,615,321 | -221,489 | 46,230,000 | -4,025,000 | $28.62 |
| 06/30/2018 | Intellia Therapeutics, Inc. | NTLA | 1,836,810 | -442,978 | 50,255,000 | 2,174,000 | $27.36 |
| 03/31/2018 | Intellia Therapeutics, Inc. | NTLA | 2,279,788 | -1,300,000 | 48,081,000 | -20,723,000 | $21.09 |
| 12/31/2017 | Intellia Therapeutics, Inc. | NTLA | 3,579,788 | 0 | 68,804,000 | -20,154,000 | $19.22 |
| 09/30/2017 | Intellia Therapeutics, Inc. | NTLA | 3,579,788 | -150,000 | 88,958,000 | 29,281,000 | $24.85 |
| 06/30/2017 | Intellia Therapeutics, Inc. | NTLA | 3,729,788 | 0 | 59,677,000 | 7,124,000 | $16.00 |
| 03/31/2017 | Intellia Therapeutics, Inc. | NTLA | 3,729,788 | -700,000 | 52,553,000 | -5,522,000 | $14.09 |
| 12/31/2016 | Intellia Therapeutics, Inc. | NTLA | 4,429,788 | 4,429,788 | 58,075,000 | 58,075,000 | $13.11 |
| << Prev Next >> |
|